SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC
Q3 2020 13F-HR Holdings
Net value change ($000)
+322,462
(19.3%)
New positions
14
Sold out positions
20
Turnover %
24.4%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| TSLA | 59,478 | 68.9% |
| FOUR | 47,021 | 1314.9% |
| LAD | 30,145 | 96.2% |
| ADPT | 28,733 | 237.6% |
| ENPH | 27,881 | 88.7% |
| AMD | 26,685 | NEW |
| Horizon Therapeutics Public Ltd Co | 24,930 | 54.0% |
| IPHI | 24,775 | 878.5% |
| FVRR | 22,365 | 77.3% |
| 1Life Healthcare Inc | 19,801 | 136.3% |
Top Reduces (Value $000, Stocks/ETFs)
| AMAT | -30,122 | -100.0% |
| EHTH | -24,766 | -100.0% |
| UBER | -23,599 | -97.0% |
| UNH | -18,965 | -100.0% |
| DT | -18,819 | -85.7% |
| SVB FINANCIAL GROUP | -17,221 | -100.0% |
| Livongo Health, Inc. | -16,311 | -100.0% |
| CRWD | -13,594 | -19.2% |
| Silk Road Medical Inc | -13,575 | -100.0% |
| MU | -12,333 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
556,838
(27.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|